Autoimmunity to Tropomyosin Isoforms in Ulcerative Colitis (UC) Patients and Unaffected Relatives

Overview

Journal Clin Exp Immunol

Publisher Oxford University Press

Specialty Allergy & Immunology

Date 1998 Aug 26

PMID 9717968

Citations 12

Authors

L Biancone

G Monteleone

R Marasco

F Pallone

Affiliations

Soon will be listed here.

Abstract

Autoimmunity to cytoskeletal protein tropomyosin (TM) has been demonstrated in UC. However, the TM isoforms involved in this IgG-mediated autoimmune response in UC and the possible presence of serum IgG antibodies against TM (hTMs IgG) in unaffected UC relatives are unknown. The aim of this study was to investigate the human TM (hTM) isoforms recognized by serum IgG from UC and to explore whether hTM IgG antibodies are present in healthy UC relatives. We studied 33 UC patients with 58 unaffected relatives, 31 Crohn's disease (CD) patients with 31 unaffected relatives and 20 controls (C). Serum IgG against four recombinant hTM isoforms (hTM1, 2, 3, 5) were tested by ELISA. p-ANCA were tested by ELISA and immunofluorescence. Serum hTM1 and hTM5 IgG were higher in UC patients than in CD and C (P<0.005). Among UC patients 52% were seropositive for hTM1 and 64% for hTM5 (P<0.001 versus CD and C). In UC, hTM5 IgG were higher in p-ANCA+ than in ANCA- patients (P=0.04). In UC relatives hTM1 IgG were higher than in CD relatives and C (P<0.01). UC relatives were more frequently seropositive for hTM1 than hTM5 IgG (P=0.001). while probands were more frequently seropositive for hTM5 IgG (P=0.008). We conclude that autoimmunity to hTMI and hTM5 is a feature of UC, while hTM1 IgG differentiate UC relatives from controls. A genetic susceptibility to immune recognition of hTM isoforms in UC is suggested.

Citing Articles

The Low-Abundance Plasma Proteome Reveals Differentially Abundant Proteins Associated with Breast Implant Capsular Contracture: A Pilot Study.

Rahman M, Amirkhani A, Mempin M, Ahn S, Deva A, Baker M Proteomes. 2024; 12(3).

PMID: 39189262 PMC: 11348101. DOI: 10.3390/proteomes12030022.

Endometriosis and inflammatory immune responses: Indian experience.

Gajbhiye R Am J Reprod Immunol. 2022; 89(2):e13590.

PMID: 35751585 PMC: 7615030. DOI: 10.1111/aji.13590.

Low Level Antibodies Against Alpha-Tropomyosin Are Associated With Increased Risk of Coronary Heart Disease.

Zhang Y, Zhao H, Liu B, Li L, Zhang L, Bao M Front Pharmacol. 2020; 11:195.

PMID: 32174839 PMC: 7056748. DOI: 10.3389/fphar.2020.00195.

Coherent somatic mutation in autoimmune disease.

Ross K PLoS One. 2014; 9(7):e101093.

PMID: 24988487 PMC: 4079513. DOI: 10.1371/journal.pone.0101093.

Proinflammatory progranulin antibodies in inflammatory bowel diseases.

Thurner L, Stoger E, Fadle N, Klemm P, Regitz E, Kemele M Dig Dis Sci. 2014; 59(8):1733-42.

PMID: 24591016 DOI: 10.1007/s10620-014-3089-3.

References

Best W, Becktel J, SINGLETON J, KERN Jr F . Development of a Crohn's disease activity index. National Cooperative Crohn's Disease Study. Gastroenterology. 1976; 70(3):439-44. View

Novy R, Lin J, Lin C, Lin J . Human fibroblast tropomyosin isoforms: characterization of cDNA clones and analysis of tropomyosin isoform expression in human tissues and in normal and transformed cells. Cell Motil Cytoskeleton. 1993; 25(3):267-81. DOI: 10.1002/cm.970250307. View

Halstensen T, Das K, Brandtzaeg P . Epithelial deposits of immunoglobulin G1 and activated complement colocalise with the M(r) 40 kD putative autoantigen in ulcerative colitis. Gut. 1993; 34(5):650-7. PMC: 1374184. DOI: 10.1136/gut.34.5.650. View

Biancone L, Mandal A, Yang H, Dasgupta T, Paoluzi A, Marcheggiano A . Production of immunoglobulin G and G1 antibodies to cytoskeletal protein by lamina propria cells in ulcerative colitis. Gastroenterology. 1995; 109(1):3-12. DOI: 10.1016/0016-5085(95)90263-5. View

Satsangi J, Jewell D, Rosenberg W, Bell J . Genetics of inflammatory bowel disease. Gut. 1994; 35(5):696-700. PMC: 1374760. DOI: 10.1136/gut.35.5.696. View

Bikle D, Munson S, Morrison N, Eisman J . Zipper protein, a newly described tropomyosin-like protein of the intestinal brush border. J Biol Chem. 1993; 268(1):620-6. View

Roussomoustakaki M, Satsangi J, Welsh K, Louis E, Fanning G, Targan S . Genetic markers may predict disease behavior in patients with ulcerative colitis. Gastroenterology. 1997; 112(6):1845-53. DOI: 10.1053/gast.1997.v112.pm9178675. View

Monteleone G, Marasco R, Parrello T, De Medici A, Giglio A, Doldo P . Low Prevalence of p-ANCA in Unaffected Relatives of Patients with Ulcerative Colitis from a Mediterranean Area. Inflamm Bowel Dis. 2013; 2(1):11-5. View

Imagawa D, Osifchin N, Paznekas W, Shin M, Mayer M . Consequences of cell membrane attack by complement: release of arachidonate and formation of inflammatory derivatives. Proc Natl Acad Sci U S A. 1983; 80(21):6647-51. PMC: 391227. DOI: 10.1073/pnas.80.21.6647. View

10.

Gomes P, du Boulay C, Smith C, Holdstock G . Relationship between disease activity indices and colonoscopic findings in patients with colonic inflammatory bowel disease. Gut. 1986; 27(1):92-5. PMC: 1433178. DOI: 10.1136/gut.27.1.92. View

11.

Orholm M, Iselius L, Sorensen T, Munkholm P, Langholz E, Binder V . Investigation of inheritance of chronic inflammatory bowel diseases by complex segregation analysis. BMJ. 1993; 306(6869):20-4. PMC: 1676367. DOI: 10.1136/bmj.306.6869.20. View

12.

Duerr R, Targan S, Landers C, Sutherland L, Shanahan F . Anti-neutrophil cytoplasmic antibodies in ulcerative colitis. Comparison with other colitides/diarrheal illnesses. Gastroenterology. 1991; 100(6):1590-6. DOI: 10.1016/0016-5085(91)90657-7. View

13.

Burgess D, Broschat K, Hayden J . Tropomyosin distinguishes between the two actin-binding sites of villin and affects actin-binding properties of other brush border proteins. J Cell Biol. 1987; 104(1):29-40. PMC: 2117036. DOI: 10.1083/jcb.104.1.29. View

14.

Novy R, Sellers J, Liu L, Lin J . In vitro functional characterization of bacterially expressed human fibroblast tropomyosin isoforms and their chimeric mutants. Cell Motil Cytoskeleton. 1993; 26(3):248-61. DOI: 10.1002/cm.970260308. View

15.

Geng X, Biancone L, Dai H, Lin J, Yoshizaki N, Dasgupta A . Tropomyosin isoforms in intestinal mucosa: production of autoantibodies to tropomyosin isoforms in ulcerative colitis. Gastroenterology. 1998; 114(5):912-22. DOI: 10.1016/s0016-5085(98)70310-5. View

16.

Heiner D . Significance of immunoglobulin G subclasses. Am J Med. 1984; 76(3A):1-6. DOI: 10.1016/0002-9343(84)90313-9. View

17.

Lee J, Lennard-Jones J . Inflammatory bowel disease in 67 families each with three or more affected first-degree relatives. Gastroenterology. 1996; 111(3):587-96. DOI: 10.1053/gast.1996.v111.pm8780561. View

18.

Seibold F, Slametschka D, Gregor M, Weber P . Neutrophil autoantibodies: a genetic marker in primary sclerosing cholangitis and ulcerative colitis. Gastroenterology. 1994; 107(2):532-6. DOI: 10.1016/0016-5085(94)90181-3. View

19.

Bhakdi S, Kaflein R, Halstensen T, Hugo F, Preissner K, Mollnes T . Complement S-protein (vitronectin) is associated with cytolytic membrane-bound C5b-9 complexes. Clin Exp Immunol. 1988; 74(3):459-64. PMC: 1542007. View

20.

Halstensen T, Mollnes T, Brandtzaeg P . Persistent complement activation in submucosal blood vessels of active inflammatory bowel disease: immunohistochemical evidence. Gastroenterology. 1989; 97(1):10-9. DOI: 10.1016/0016-5085(89)91409-1. View